PMFA
LGND icon

Plante Moran Financial Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Plante Moran Financial Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-53
Closed -$4K – 961
2015
Q4 		$4K Buy
+53
New +$3.27K ﹤0.01% 769

Other funds holding LGND

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Plante Moran Financial Advisors's LGND Position: Q1 2016 in Review

Plante Moran Financial Advisors sold out of Ligand Pharmaceuticals (LGND) in Q1 2016, closing a stake of 53 shares — an estimated $4K sold.

Plante Moran Financial Advisors first reported a position in LGND in Q4 2015 and held it in 1 quarter. The position peaked at $4K in Q4 2015. 251 funds tracked by Wall St. Rank hold LGND as of Q1 2016.

  • Plante Moran Financial Advisors reported no remaining Ligand Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 53 Ligand Pharmaceuticals shares in Q1 2016, an estimated $4K.
  • Plante Moran Financial Advisors first reported a position in Ligand Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Ligand Pharmaceuticals position peaked at $4K in Q4 2015.
  • 251 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2016.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.